Patient Safety & Quality Healthcare (PSQH) discussed IV infiltration and it’s potential for life-threatening consequences in a recent article. The piece, “Companies Work to Help Combat IV Infiltrations” includes commentary from ivWatch President and CEO, Gary Warren, and cites the ivWatch Model 400 as a clinician partner helping to deliver improved patient care with constant monitoring of the IV site. Read the full article here.
ICYMI: The Summer 2019 issue of JAVA includes a study describing the performance of the ivWatch Model 400, including comparing technology notifications to clinicians’ assessments in the early detection of IV infiltration. Read more about the study: https://t.co/dEvouDurj8
Discover how early detection of IV infiltration can be an integral step in your efforts to enhance patient safety and improve outcomes. https://t.co/YZ2jBhQeyf
Summer JAVA: Everly’s Intravenous Infiltration Journey – read this Patient Perspective story through the eyes of a pediatric patient’s mother here: https://t.co/UThTg7FcfN